Safety of Preoperative Heparin for Prevention of Thrombus in Patients Undergoing Thoracoscopic Surgery
Sun Ping,Wang Luming,Xu Jun,Wang Yiqing,Lyu Wang,Hu Jian
DOI: https://doi.org/10.3877/cma.j.issn.1674-6880.2019.04.006
2019-01-01
Abstract:Objective To evaluate the safety of preoperative low molecular weight heparin (LMWH) for the prevention of thrombus in patients undergoing thoracoscopic surgery. Methods Betwwen January 2018 and June 2018, 76 patients undergoing thoracoscopic surgery in the First Affiliated Hospital, College of Medicine, Zhejiang University were randomly divided into the case group (38 cases) and control group (38 cases). Among them, 6 patients in each group were converted to open surgery, and 32 patients were included in each group finally. For patients in the case group, 12 500 IU of LMWH was correctly used after admission once a day, and lasted until discharge. Patients in the control group were injected subcutaneously with 12 500 IU of LMWH once a day from the first day after operation to discharge. General data, duration of postoperative LMWH, operating time, intraoperative bleeding, postoperative platelet count, postoperative international normalized ratio (INR), postoperative drainage time, and daily mean drainage betwwen two groups were compared. Results For patients undergoing thoracoscopic surgery, the duration of preoperative LMWH was (2.8 ± 1.3) d in the case group, and no LMWH was given before the operation in the control group. The duration of postoperative LMWH [(4.3 ± 1.7) d vs. (4.5 ± 2.2) d], operating time [(164 ± 107) min vs. (133 ± 69) min], intraoperative bleeding [(131 ± 86) mL vs. (96 ± 88) mL], postoperative platelet count [(188 ± 69) × 109/L vs. (169 ± 31) × 109/L], postoperative INR [(1.03 ± 0.11) vs. (1.00 ± 0.09)], postoperative drainage time [(3.6 ± 1.6) d vs. (3.8 ± 1.8) d] and daily mean drainage [(256 ± 89) mL vs. (204 ± 104) mL] were not significantly different between the case group and control group (t = 0.988, 5.026, 4.187, 1.288, 0.597, 0.492, 3.479; P = 0.629, 0.398, 0.256, 0.261, 0.277, 0.472, 0.145). Conclusion For patients undergoing thoracoscopic surgery, it is safe and feasible to use LMWH for preventing thrombus before operation. Key words: Heparin, low-molecular-weight; Preoperative; Postoperative; Thrombus prevention; Safety